AR105950A1 - A FORMULATION READY TO USE FOR INJECTION OF VINCRISTINE SULFATE LIPOSOMES - Google Patents

A FORMULATION READY TO USE FOR INJECTION OF VINCRISTINE SULFATE LIPOSOMES

Info

Publication number
AR105950A1
AR105950A1 ARP160102224A ARP160102224A AR105950A1 AR 105950 A1 AR105950 A1 AR 105950A1 AR P160102224 A ARP160102224 A AR P160102224A AR P160102224 A ARP160102224 A AR P160102224A AR 105950 A1 AR105950 A1 AR 105950A1
Authority
AR
Argentina
Prior art keywords
injection
vincristine sulfate
formulation ready
sulfate liposomes
liposomes
Prior art date
Application number
ARP160102224A
Other languages
Spanish (es)
Inventor
Zhang Yuanpeng
Luo Bing
Malcolm Abra Robert
T Monte William
Original Assignee
Spectrum Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spectrum Pharmaceuticals Inc filed Critical Spectrum Pharmaceuticals Inc
Publication of AR105950A1 publication Critical patent/AR105950A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composiciones que comprenden formulaciones neoplásicas y sus métodos de uso.Compositions comprising neoplastic formulations and their methods of use.

ARP160102224A 2015-07-22 2016-07-22 A FORMULATION READY TO USE FOR INJECTION OF VINCRISTINE SULFATE LIPOSOMES AR105950A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201561195711P 2015-07-22 2015-07-22

Publications (1)

Publication Number Publication Date
AR105950A1 true AR105950A1 (en) 2017-11-29

Family

ID=60452281

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160102224A AR105950A1 (en) 2015-07-22 2016-07-22 A FORMULATION READY TO USE FOR INJECTION OF VINCRISTINE SULFATE LIPOSOMES

Country Status (1)

Country Link
AR (1) AR105950A1 (en)

Similar Documents

Publication Publication Date Title
AR121273A2 (en) ENZYMATIC INHIBITORS FOR USE IN MEDICINE AND PHARMACEUTICAL COMPOSITION THAT COMPRISES THEM
CL2018000595A1 (en) Anti-PD1 antibodies and methods of use
CU20180059A7 (en) INHIBITING COMPOUNDS OF THE QUINASA DE UNIÓN A TANK
CL2016003261A1 (en) Formulation comprising a gemcitabine prodrug
CL2015002239A1 (en) Modulators of methyl modifying enzymes, compositions comprising them and their uses
CL2019000189A1 (en) New anti-claudin antibodies and their methods of use. (divisional application 201801481)
CR20150549A (en) HETEROCYCLIC COMPOUNDS AND THEIR USES
CR20160500A (en) ANTI-OX40 ANTIBODIES AND METHODS OF USE
CL2018001722A1 (en) New anti-mfi2 antibodies and methods of use (divisional application 201700506)
DOP2015000219A (en) HETEROARILO COMPOUNDS AND ITS USES
ECSP14007644A (en) INTRANASAL COMPOSITIONS OF DEXMEDETOMIDINE AND METHODS OF USE OF THEM
GT201700023A (en) OPTIONALLY CONDENSED HYDERO-CYCLIC DERIVATIVES OF PIRIDIMINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGICAL AND AUTOINMUNITY DISEASES
CL2017000716A1 (en) Rorc2 pyrrolopyridine modulators substituted with methyl and trifluoromethyl and methods of use thereof
DK3386991T3 (en) POLYCYCLIC COMPOUNDS AS INHIBITORS OF BRUTON'S TYROSINKINASE
UY36287A (en) COMPOUND OF OBJECTIVE TO IL-23A and TNF-ALFA AND USE OF THE SAME
CO2017001389A2 (en) Azetidinyloxyphenylpyrrolidine compounds
SV2016005293A (en) AMIDO-REPLACED AZOL COMPOUNDS AS INHIBITORS OF TNKS1 AND / OR TNKS2
CR20180089A (en) USEFUL COMPOUNDS TO INHIBIT ROR-GAMMA-T
BR112017002090A2 (en) factor formulation viii
BR112017007753A2 (en) use of a cosmetic composition comprising 10-hydroxostearic acid.
DOP2020000104A (en) METHODS OF USE AND COMPOSITIONS CONTAINING DULAGLUTIDA
TWD192672S (en) Cartridge bladder
GT201300225A (en) TIENO (2,3-D) DERIVED FROM PIRIMIDINE AND ITS USE FOR THE TREATMENT OF ARRITMIA
CL2018002848A1 (en) Liquid phosphoplatin formulations
NI201800016A (en) HERBICIDE COMPOSITION AND PROCESS TO PREPARE IT